FDA Approves New Treatment for Advanced Soft Tissue Sarcoma

Share this content:
FDA Approves New Treatment for Advanced Soft Tissue Sarcoma
FDA Approves New Treatment for Advanced Soft Tissue Sarcoma

WEDNESDAY, Oct. 19, 2016 (HealthDay News) -- Lartruvo (olaratumab) has been approved by the U.S. Food and Drug Administration to treat adults with certain soft tissue sarcomas.

Lartruvo, a platelet-derived growth factor receptor-alpha blocking antibody, has been sanctioned for use with doxorubicin in cases that cannot be treated with radiation or surgery, the FDA said Wednesday in a news release.

The drug was evaluated in clinical trials involving 133 patients with soft tissue carcinomas. Average survival among patients who took Lartruvo and doxorubicin was 8.2 months, compared with 4.4 months among patients who took doxorubicin alone. Potential side effects identified during the studies included harm to a developing fetus, hypotension, fever, chills, nausea, fatigue, neutropenia, and musculoskeletal pain.

Lartruvo's maker, Indianapolis-based Eli Lilly and Company, is conducting a larger study to further evaluate the drug's effectiveness among numerous types of soft tissue sarcoma, the agency said.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

AAN: Alpha-Synuclein Levels in Tears May Help ID Parkinson's

AAN: Alpha-Synuclein Levels in Tears May Help ID ...

PD patients have significantly decreased total alpha-synuclein in tears compared with healthy controls

Younger Onset of T2DM Linked to Increased Mortality Risk

Younger Onset of T2DM Linked to Increased Mortality ...

Earlier diagnosis of T2DM tied to increased mortality, mainly driven by cardiovascular disease mortality

Menopausal Hormone Therapy Tied to Less Pronounced Kyphosis

Menopausal Hormone Therapy Tied to Less Pronounced Kyphosis

Continuous and remote past HT users had less kyphosis in minimally-, fully-adjusted models

is free, fast, and customized just for you!

Already a member?

Sign In Now »